JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1677/jme.0.0220161
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (30)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uchide, T
Right arrow Articles by Saida, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uchide, T
Right arrow Articles by Saida, K
Journal of Molecular Endocrinology, Vol 22, Issue 2, 161-171
Copyright © 1999 by Society for Endocrinology

Articles

Gene expression of vasoactive intestinal contractor/endothelin-2 in ovary, uterus and embryo: comprehensive gene expression profiles of the endothelin ligand-receptor system revealed by semi-quantitative reverse transcription-polymerase chain reaction analysis in adult mouse tissues and during late embryonic development

T Uchide, H Masuda, Y Mitsui, and K Saida


Vasoactive intestinal contractor (VIC)/endothelin-2 (ET-2) is a 21 amino acid intestinal peptide characterized as a potent vasoactive and intestinal smooth muscle-contracting compound. To investigate the physiological roles of VIC/ET-2 further, we characterized the specificity of VIC gene expression relative to that of other members of the endothelin (ET) ligand-receptor system in adult mouse tissues and during embryonic development. Gene expression of ET-1, ET-3, ETA and ETB was ubiquitous in almost all tissues we examined while gene expression of VIC was localized to certain tissues. A high level of VIC gene expression was observed in ovary and uterus. The gene expression of VIC, relative to that of glyceraldehyde-3-phosphate dehydrogenase, was approximately 2.0%, 0.4%, and 2.3% in ovary, uterus, and intestine respectively, and was approximately 1.6 and 7. 1 times higher than that of ET-1 in ovary and intestine respectively. Thus, VIC may have some physiological role in adult ovary and uterus as well as intestine. In embryonic development, VIC gene expression sharply increased between 11 and 15 days post coitus and decreased after birth, suggesting an involvement in the later stages of embryonic development.


This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
M J Grimshaw
Endothelins and hypoxia-inducible factor in cancer
Endocr. Relat. Cancer, June 1, 2007; 14(2): 233 - 244.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
T. SUZUKI, Y. Y. UETA, N. INOUE, X. XUAN, H. SAITOH, and H. SUZUKI
BENEFICIAL EFFECT OF ERYTHROPOIETIN ADMINISTRATION ON MURINE INFECTION WITH TRYPANOSOMA CONGOLENSE
Am J Trop Med Hyg, June 1, 2006; 74(6): 1020 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
S. Takizawa, T. Uchide, J. Adur, T. Kozakai, E. Kotake-Nara, J. Quan, and K. Saida
Differential expression of endothelin-2 along the mouse intestinal tract
J. Mol. Endocrinol., October 1, 2005; 35(2): 201 - 209.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
T. Uchide, H. Masuda, Y.-S. Lee, Y. Makiyama, Y. Mitsui, and K. Saida
Fluctuating Gene Expression and Localized Cellular Distribution of Vasoactive Intestinal Contractor (VIC) in Mouse Uterus
J. Histochem. Cytochem., May 1, 2000; 48(5): 699 - 708.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society for Endocrinology.